aplaviroc
aplaviroc
| SMILES | CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 |
| InChIKey | GWNOTCOIYUNTQP-FQLXRVMXSA-N |
Chemical Properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 3 |
| Rotatable bonds | 10 |
| Molecular weight (Da) | 577.3 |
Database connections
| Ligand site mutations | CCR5 |
No bioactivity data available.
aplaviroc
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
Phase II
Phase III
Phase IV
Database connections
| Ligand site mutations | CCR5 |